Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

How To Front-Run Rising Rates

Published 01/19/2021, 04:10 AM
Updated 04/03/2018, 07:55 AM

Long-term interest rates have awoken. The trend toward higher Treasury yields is likely just getting started, which makes 2021 an “inflection year” for us income investors.

And what better way to celebrate the paradigm shift than to buy dividend payers that are likely to double (or better!) in the months and years ahead?

Sure, some fixed-income plays are going to be punished. That’s a topic for another time. Today, we should focus on shareholder-yield darlings that see their profits increase in an outsized manner when interest rates climb.

I’m talking about stocks that will shower us with:

  • Current yields today,
  • Dividend raises tomorrow,
  • Generous stock buybacks, and (most importantly)
  • Share prices that will climb dramatically.

I’m talking about “boring” old insurance stocks. These income-investor favorites are going to absolutely roll as interest rates rise.

And make no mistake, rates are already rising, with the yield on 10-year Treasuries recently eclipsing 1%. That may not sound like a big move up, but remember that the T-note yielded just 0.5% in August, so 1% is an important psychological barrier.

Now that it’s breached that level, it could be off to the races. In fact, it already is:

Treasury Yields Soar …
10 Yr Treasury Chart

This is where insurers come in, because there’s a direct line between rising Treasury rates and their profits. You can see that connection in the shares of MetLife (NYSE:MET), the biggest life insurer in the US by market share, which lurched higher with Treasury rates—and have tacked on a 7% gain since Jan. 1 alone:

… Taking MetLife Shares With Them
MET-Share Price Chart

That’s no surprise: investors are simply front-running the higher profits MET and other insurers are certain to see from higher rates.

I say “certain” because insurers are constantly investing the premiums they collect in, among other things, government and corporate bonds, and yields on those bonds rise with Treasury yields. Those higher yields fatten insurers’ net interest margins, or the difference between investment returns and claims paid out to policyholders.

2 Insurance Stocks to Buy for Rate-Driven Dividend Growth in 2021

Let’s stick with MetLife, because the company, which boasts $600 billion in assets under management, already puts us dividend investors in the starting blocks with a nice 3.6% yield.

Speaking of dividends, back in 2013, the Federal Reserve let MetLife off the hook—MET had been classed as a bank-holding company and was therefore tied to payout-limiting stress tests. Since then, management has been footloose and fancy free with its dividend—and guess what? They were proven right.

MetLife’s Payout Lurches Back to Life, Grows Steadily
MET-Dividend Growth

That’s a pretty big clue that the stress tests were unnecessary: MetLife pays just 14.4% of its last 12 months of free cash flow (FCF) as dividends today, so it could more than triple its payout tomorrow and still be well below the 50% of FCF I consider the dividend safety line.

Its balance sheet is also spotless, with long-term debt down 14% in the past five years and, at $18 billion, just 23% of its $780 billion in assets. And we can expect that percentage to shrink as rising rates inflate its assets.

And yet, despite all this, we can buy MET for a ridiculously low 8-times its last 12 months of earnings! The stock also trades at 61% of book value, or less than the value of its assets if it were broken up and sold today. (In other words, we’re basically getting its business, including its household-name brand, for free!)

Throw in the rising 10-year Treasury yield and more dividend-driven upside (MET’s payout has pulled its share price higher since the Fed took off the shackles), and you get a recipe for even further gains:

MetLife’s Payout Pulls Up Its Price—Point for Point
MET-Price Dividend Chart

Finally, MET recently resumed its buyback program, showing that management agrees that this stock is too cheap (a nice cue for us). The firm’s repurchases lead to fewer shares outstanding, helping boost the value of those still in circulation.

Another Insurer With Rate-Driven Upside

Lincoln National Corporation (NYSE:LNC), the sixth-biggest life insurer by market share, trades at less than half of book value today—just 46%. That’s higher than the 30% of book at which it traded in late 2020, but it’s still near historic lows (and another case where we’re basically getting a landmark business for free).

It’s also ridiculous when you consider LNC’s sterling dividend-growth rate and the fact that it’s bought back nearly half of its outstanding shares in the last decade.

LNC-Share Performance

Source: Lincoln Financial November 2020 Investor Presentation

Those buybacks include 5.5 million shares repurchased between September 2019 and September 2020. The company did put its repurchases on hold in the third quarter of 2020, but I expect them to resume as rates rise, naturally increasing its assets under management and lifting its underwriting profits.

Buying now also gets you in on a devoted dividend grower: the payout yields 3.1% today and has exploded from just a penny a share (after LNC cut during the 2008/’09 crisis) to $0.42 today—a 4,100% increase in a little over a decade! Put another way, if you’d bought back then, you’d be yielding upwards of 6% on your LNC stake today.

Lincoln’s Payout Stair-Steps to the Sky
LNC-Dividend Growth

There’s more to come: even though LNC’s payout ratio is a slightly elevated 60% of its last 12 months of FCF, that still looks safe when you consider the impact of rising rates and the firm’s strong balance sheet, with just $6.7 billion in long-term debt, a small fraction of both its total assets (of just under $348 billion) and its cash and short-term investments (of $121 billion).

This Incredible Rising-Rate Buy Grows Dividends 224% (yours in 2 clicks!)

Let’s not stop with insurers. I’ve got another play for you that is, hands down, the easiest way to double our dividend money in 2021.

It’s a small, nimble firm with great relationships with its customers; it’s dirt cheap—like our two insurers, it trades for less than book value—AND it yields a gaudy 4.2%. Its dividend is en fuego, too, having popped 224% in just five years!

Throw in a raft of share buybacks and a share price that’s come “undone” from payout growth and you get a recipe for an EASY double here—in short order.

This Rising-Rate Play Gives Us 3 Ways to Win
Bank Metrics Chart

Disclosure: Brett Owens and Michael Foster are contrarian income investors who look for undervalued stocks/funds across the U.S. markets. Click here to learn how to profit from their strategies in the latest report, "7 Great Dividend Growth Stocks for a Secure Retirement."

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.